Holen Sie sich die Stockscreener-App
82.71
3.00%
2.41
Handel nachbörslich:
82.65
-0.06
-0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever - The Motley Fool
Stock Watch: Sanofi And Merck Temper Big Pharma Q2 Earnings Cheer - insights.citeline.com
What's Going On With Merck Stock Tuesday?Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE) - Benzinga
IO Biotech's cancer vaccine shows improvement, but narrowly misses study goal - Reuters
Merck to Begin Phase 3 Trials for Investigational Monthly HIV Prevention Pill - Insider Monkey
Merck KGaA Plans $4 Billion Bond Sale to Fund SpringWorks Therapeutics Acquisition - Bloomberg.com
Goldman Sachs Slashes PT on Merck & Co. (MRK) to $94 From $99, Keeps a Buy Rating - MSN
Merck & Co. (MRK) Divests Surface Solutions for €665 million - MSN
Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating - MSN
Verona’s COPD Launch Success Sealed Merck Buyout Interest - insights.citeline.com
Merck & Co Inc Options Trading: September 26th Expiration - AInvest
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know - Yahoo Finance
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda - Yahoo Finance
Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline - MSN
10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar
11 Cheap Pharmaceutical Stocks to Buy Now - Insider Monkey
Merck & Co., Inc. (MRK) Needs To Move On From Talking About Its Animal Division, Says Jim Cramer - MSN
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027 - PharmExec
Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRM - MSN
N.J.-based Merck announces $3B in cost cutting measures including layoffs - NJ.com
Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns - Benzinga
Merck & Co., Inc. (NYSE:MRK) Q2 2025 Earnings Call Transcript - Insider Monkey
Merck Layoffs Announced: Axing Both Land and Labor In One Fell Swoop - The HR Digest
Merck & Co Inc (MRK) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Merck & Co.’s Winrevair Growing Into The Revenue Driver Needed Post-Keytruda LOE - insights.citeline.com
Merck Stock Is Almost A Classical Benjamin Graham Investment - Seeking Alpha
Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed - TradingView
Merck will lay off employees and shed some real estate to cut $3 billion in costs - MSN
Earnings call transcript: Merck Q2 2025 beats EPS, stock dips on revenue miss - Investing.com
Why Is Merck Stock Falling On Tuesday?Merck & Co (NYSE:MRK) - Benzinga
MRK Earnings: Merck & Co Q2 adj. profit drops on lower sales - AlphaStreet
Merck Cuts $3 Billion in Costs as Keytruda Reign Nears End - MSN
Merck posts Q2 earnings miss, unveils cost-cutting initiative - Proactive financial news
Merck Mounts $3 Billion Revamp as Keytruda Price Pressure Looms - Bloomberg.com
Merck & Co., Inc. Reports Mixed Second-Quarter 2025 Results - Tokenist
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results - BioSpace
Merck & Co. Announces New Restructuring Program - TipRanks
Merck in Charts: KEYTRUDA sales surge 9% Y/Y, GARDASIL dips 54% in Q2 (NYSE:MRK) - Seeking Alpha
Merck plans $3B annual cost cuts as Keytruda faces patent cliff (MRK:NYSE) - Seeking Alpha
Merck & Co Inc. Q2 Profit Decreases, But Beats Estimates - Nasdaq
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):